Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1686

1.

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.

J Allergy Clin Immunol. 2006 Apr;117(4):802-9.

PMID:
16630937
2.

Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.

Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.

Clin Ther. 2011 Jul;33(7):828-40. doi: 10.1016/j.clinthera.2011.06.006. Epub 2011 Jul 7.

PMID:
21741092
3.
5.

Safety and tolerability of an SQ-standardized GRAss ALlergy immunotherapy tablet (GRAZAX®) in a real-life setting for three consecutive seasons - the GRAAL trial.

Wessel F, Chartier A, Meunier JP, Magnan A.

Clin Drug Investig. 2012 Jul 1;32(7):451-63. doi: 10.2165/11634270-000000000-00000.

PMID:
22594491
6.
7.

Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.

Senna GE, Calderon M, Milani M.

Expert Rev Clin Immunol. 2011 Jan;7(1):21-7. doi: 10.1586/eci.10.89.

PMID:
21162646
8.
9.

Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children.

Ibañez MD, Kaiser F, Knecht R, Armentia A, Schöpfer H, Tholstrup B, Bufe A.

Pediatr Allergy Immunol. 2007 Sep;18(6):516-22.

PMID:
17680910
10.

Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years.

Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Riis B, Grønager PM, Durham SR.

J Allergy Clin Immunol. 2008 Feb;121(2):512-518.e2. Epub 2007 Dec 26.

PMID:
18155284
11.

Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet.

Nelson H, Lehmann L, Blaiss MS.

Curr Med Res Opin. 2012 Jun;28(6):1043-51. doi: 10.1185/03007995.2012.684676. Epub 2012 May 9. Review.

PMID:
22502864
12.

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy.

Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L, Knecht R, Stephan V, Tholstrup B, Weisshaar C, Kaiser F.

J Allergy Clin Immunol. 2009 Jan;123(1):167-173.e7. doi: 10.1016/j.jaci.2008.10.044.

PMID:
19130937
13.

Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.

Roberts G, Hurley C, Turcanu V, Lack G.

J Allergy Clin Immunol. 2006 Feb;117(2):263-8.

PMID:
16461125
14.

Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.

Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M, Melac M, Malling HJ.

J Allergy Clin Immunol. 2011 Sep;128(3):559-66. doi: 10.1016/j.jaci.2011.06.022. Epub 2011 Jul 29.

PMID:
21802126
15.

Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets.

Malling HJ, Lund L, Ipsen H, Poulsen L.

J Investig Allergol Clin Immunol. 2006;16(3):162-8.

16.

Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial.

Lima MT, Wilson D, Pitkin L, Roberts A, Nouri-Aria K, Jacobson M, Walker S, Durham S.

Clin Exp Allergy. 2002 Apr;32(4):507-14.

PMID:
11972594
17.
18.

Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.

Cox LS, Casale TB, Nayak AS, Bernstein DI, Creticos PS, Ambroisine L, Melac M, Zeldin RK.

J Allergy Clin Immunol. 2012 Dec;130(6):1327-34.e1. doi: 10.1016/j.jaci.2012.08.032. Epub 2012 Oct 31.

PMID:
23122534
19.

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.

Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W.

Allergy. 2004 May;59(5):498-504.

20.

Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis - a Northern European perspective.

Bachert C, Vestenbaek U, Christensen J, Griffiths UK, Poulsen PB.

Clin Exp Allergy. 2007 May;37(5):772-9.

PMID:
17456225

Supplemental Content

Support Center